Cargando…

Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid

Propionic acid (PPA) is a ubiquitous short-chain fatty acid which is a fermentation product of the enteric microbiome and present or added to many foods. While PPA has beneficial effects, it is also associated with human disorders, including autism spectrum disorders (ASDs). We previously demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Frye, Richard E., Nankova, Bistra, Bhattacharyya, Sudeepa, Rose, Shannon, Bennuri, Sirish C., MacFabe, Derrick F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744079/
https://www.ncbi.nlm.nih.gov/pubmed/29312285
http://dx.doi.org/10.3389/fimmu.2017.01670
_version_ 1783288681407184896
author Frye, Richard E.
Nankova, Bistra
Bhattacharyya, Sudeepa
Rose, Shannon
Bennuri, Sirish C.
MacFabe, Derrick F.
author_facet Frye, Richard E.
Nankova, Bistra
Bhattacharyya, Sudeepa
Rose, Shannon
Bennuri, Sirish C.
MacFabe, Derrick F.
author_sort Frye, Richard E.
collection PubMed
description Propionic acid (PPA) is a ubiquitous short-chain fatty acid which is a fermentation product of the enteric microbiome and present or added to many foods. While PPA has beneficial effects, it is also associated with human disorders, including autism spectrum disorders (ASDs). We previously demonstrated that PPA modulates mitochondrial dysfunction differentially in subsets of lymphoblastoid cell lines (LCLs) derived from patients with ASD. Specifically, PPA significantly increases mitochondrial function in LCLs that have mitochondrial dysfunction at baseline [individuals with autistic disorder with atypical mitochondrial function (AD-A) LCLs] as compared to ASD LCLs with normal mitochondrial function [individuals with autistic disorder with normal mitochondrial function (AD-N) LCLs] and control (CNT) LCLs. PPA at 1 mM was found to have a minimal effect on expression of immune genes in CNT and AD-N LCLs. However, as hypothesized, Panther analysis demonstrated that 1 mM PPA exposure at 24 or 48 h resulted in significant activation of the immune system genes in AD-A LCLs. When the effect of PPA on ASD LCLs were compared to the CNT LCLs, both ASD groups demonstrated immune pathway activation, although the AD-A LCLs demonstrate a wider activation of immune genes. Ingenuity Pathway Analysis identified several immune-related pathways as key Canonical Pathways that were differentially regulated, specifically human leukocyte antigen expression and immunoglobulin production genes were upregulated. These data demonstrate that the enteric microbiome metabolite PPA can evoke atypical immune activation in LCLs with an underlying abnormal metabolic state. As PPA, as well as enteric bacteria which produce PPA, have been implicated in a wide variety of diseases which have components of immune dysfunction, including ASD, diabetes, obesity, and inflammatory diseases, insight into this metabolic modulator may have wide applications for both health and disease.
format Online
Article
Text
id pubmed-5744079
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57440792018-01-08 Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid Frye, Richard E. Nankova, Bistra Bhattacharyya, Sudeepa Rose, Shannon Bennuri, Sirish C. MacFabe, Derrick F. Front Immunol Immunology Propionic acid (PPA) is a ubiquitous short-chain fatty acid which is a fermentation product of the enteric microbiome and present or added to many foods. While PPA has beneficial effects, it is also associated with human disorders, including autism spectrum disorders (ASDs). We previously demonstrated that PPA modulates mitochondrial dysfunction differentially in subsets of lymphoblastoid cell lines (LCLs) derived from patients with ASD. Specifically, PPA significantly increases mitochondrial function in LCLs that have mitochondrial dysfunction at baseline [individuals with autistic disorder with atypical mitochondrial function (AD-A) LCLs] as compared to ASD LCLs with normal mitochondrial function [individuals with autistic disorder with normal mitochondrial function (AD-N) LCLs] and control (CNT) LCLs. PPA at 1 mM was found to have a minimal effect on expression of immune genes in CNT and AD-N LCLs. However, as hypothesized, Panther analysis demonstrated that 1 mM PPA exposure at 24 or 48 h resulted in significant activation of the immune system genes in AD-A LCLs. When the effect of PPA on ASD LCLs were compared to the CNT LCLs, both ASD groups demonstrated immune pathway activation, although the AD-A LCLs demonstrate a wider activation of immune genes. Ingenuity Pathway Analysis identified several immune-related pathways as key Canonical Pathways that were differentially regulated, specifically human leukocyte antigen expression and immunoglobulin production genes were upregulated. These data demonstrate that the enteric microbiome metabolite PPA can evoke atypical immune activation in LCLs with an underlying abnormal metabolic state. As PPA, as well as enteric bacteria which produce PPA, have been implicated in a wide variety of diseases which have components of immune dysfunction, including ASD, diabetes, obesity, and inflammatory diseases, insight into this metabolic modulator may have wide applications for both health and disease. Frontiers Media S.A. 2017-12-22 /pmc/articles/PMC5744079/ /pubmed/29312285 http://dx.doi.org/10.3389/fimmu.2017.01670 Text en Copyright © 2017 Frye, Nankova, Bhattacharyya, Rose, Bennuri and MacFabe. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Frye, Richard E.
Nankova, Bistra
Bhattacharyya, Sudeepa
Rose, Shannon
Bennuri, Sirish C.
MacFabe, Derrick F.
Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid
title Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid
title_full Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid
title_fullStr Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid
title_full_unstemmed Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid
title_short Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid
title_sort modulation of immunological pathways in autistic and neurotypical lymphoblastoid cell lines by the enteric microbiome metabolite propionic acid
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744079/
https://www.ncbi.nlm.nih.gov/pubmed/29312285
http://dx.doi.org/10.3389/fimmu.2017.01670
work_keys_str_mv AT fryericharde modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid
AT nankovabistra modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid
AT bhattacharyyasudeepa modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid
AT roseshannon modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid
AT bennurisirishc modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid
AT macfabederrickf modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid